Satsuma Pharmaceuticals, Inc.
Pharmaceutical company · Durham, North Carolina, United States
Satsuma Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina, United States. Its earliest recorded incorporation is in 2016. It has reported private securities offerings to the US SEC, most recently $12 million sold in a notice filed in 2018.
Satsuma Pharmaceuticals at a glance
What does Satsuma Pharmaceuticals do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $12.1 million sold (2018).
Frequently asked questions about Satsuma Pharmaceuticals
Where is Satsuma Pharmaceuticals headquartered?
Satsuma Pharmaceuticals, Inc. is headquartered in Durham, North Carolina, United States.
What does Satsuma Pharmaceuticals do?
Satsuma Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was Satsuma Pharmaceuticals founded?
The earliest incorporation on record for Satsuma Pharmaceuticals, Inc. is in 2016, according to public company registers.
Similar companies
- Opus Genetics, Inc.Durham, North Carolina, United States
- Polarean, Inc.Durham, North Carolina, United States
- T3D Therapeutics, Inc.Durham, North Carolina, United States
- Chimerix IncDurham, North Carolina, United States
- LadeRx, LLCDurham, North Carolina, United States
- BioMarck Pharmaceuticals LtdDurham, North Carolina, United States
- G1 Therapeutics, Inc.Durham, North Carolina, United States
- Tellus Therapeutics, Inc.Durham, North Carolina, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences